Contract 75N90020F00003
Central Admixture Pharmacy Services, Inc · Department Of Health And Human Services · September 24, 2020
Central Admixture Pharmacy Services, Inc was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on September 24, 2020 for $204,000 of work in pharmaceutical preparation manufacturing. Performance is in Irvine, CA. This is a task or delivery order issued under parent IDIQ 75N90019D00028. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on September 24, 2021.
Contract details
- PIID
- 75N90020F00003
- Parent IDIQ
- 75N90019D00028
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Competition
- Competed Under Sap
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Medical And Surgical Instruments, Equipment, And Supplies
- Place of performance
- Irvine, CA
- First action
- September 24, 2020
- Latest action
- September 24, 2021
Description
503B COMPOUNDED PRODUCTS FROM CENTRAL ADMIXTURE PHARMACY SERVICES, INC.:1322517 [POTS: 21-007354]
Modification timeline
-
September 24, 2021Mod P00002 · Funding Only Action$270.0K
-
September 27, 2020Mod P00001 · Other Administrative ActionPATIENT CALL (20-009688)$239.6K
-
September 24, 2020Base awardWORKSTATION ON WHEELS$53.9K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Phlow Corp. | Department Of Health And Human Services | July 2, 2026 | $696.67M |
| Sri International | Department Of Health And Human Services | July 2, 2026 | $0 |
| Pfizer Inc | Department Of Health And Human Services | June 29, 2026 | $1.12B |
| Kymanox Corp | Department Of Health And Human Services | June 25, 2026 | $0 |
| Mckesson Specialty Distribution Llc | Department Of Health And Human Services | June 24, 2026 | $203.93M |
| Mriglobal | Department Of Health And Human Services | June 24, 2026 | $514.9K |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N90020F00003?
Contract 75N90020F00003 is a federal contract awarded to Central Admixture Pharmacy Services, Inc by Department Of Health And Human Services on September 24, 2020 for $204,000 of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 2 times since the base award.
Who won contract 75N90020F00003?
Central Admixture Pharmacy Services, Inc won contract 75N90020F00003 from Department Of Health And Human Services.
How much is contract 75N90020F00003 worth?
Contract 75N90020F00003 has obligated $204,000 to date, with a total potential value of $270,000 if all options are exercised.